Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice

AM. Krais, EN. Speksnijder, JP. Melis, R. Indra, M. Moserova, RW. Godschalk, FJ. van Schooten, A. Seidel, K. Kopka, HH. Schmeiser, M. Stiborova, DH. Phillips, M. Luijten, VM. Arlt,

. 2016 ; 90 (4) : 839-51. [pub] 20150521

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17001136

E-zdroje NLK Online Plný text

ProQuest Central od 2002-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2002-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2002-01-01 do Před 1 rokem

The tumour suppressor p53 is one of the most important cancer genes. Previous findings have shown that p53 expression can influence DNA adduct formation of the environmental carcinogen benzo[a]pyrene (BaP) in human cells, indicating a role for p53 in the cytochrome P450 (CYP) 1A1-mediated biotransformation of BaP in vitro. We investigated the potential role of p53 in xenobiotic metabolism in vivo by treating Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice with BaP. BaP-DNA adduct levels, as measured by (32)P-postlabelling analysis, were significantly higher in liver and kidney of Trp53(-/-) mice than of Trp53(+/+) mice. Complementarily, significantly higher amounts of BaP metabolites were also formed ex vivo in hepatic microsomes from BaP-pretreated Trp53(-/-) mice. Bypass of the need for metabolic activation by treating mice with BaP-7,8-dihydrodiol-9,10-epoxide resulted in similar adduct levels in liver and kidney in all mouse lines, confirming that the influence of p53 is on the biotransformation of the parent compound. Higher BaP-DNA adduct levels in the livers of Trp53(-/-) mice correlated with higher CYP1A protein levels and increased CYP1A enzyme activity in these animals. Our study demonstrates a role for p53 in the metabolism of BaP in vivo, confirming previous in vitro results on a novel role for p53 in CYP1A1-mediated BaP metabolism. However, our results also suggest that the mechanisms involved in the altered expression and activity of the CYP1A1 enzyme by p53 in vitro and in vivo are different.

000      
00000naa a2200000 a 4500
001      
bmc17001136
003      
CZ-PrNML
005      
20171215201520.0
007      
ta
008      
170103s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00204-015-1531-8 $2 doi
024    7_
$a 10.1007/s00204-015-1531-8 $2 doi
035    __
$a (PubMed)25995008
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Krais, Annette M $u Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
245    14
$a The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice / $c AM. Krais, EN. Speksnijder, JP. Melis, R. Indra, M. Moserova, RW. Godschalk, FJ. van Schooten, A. Seidel, K. Kopka, HH. Schmeiser, M. Stiborova, DH. Phillips, M. Luijten, VM. Arlt,
520    9_
$a The tumour suppressor p53 is one of the most important cancer genes. Previous findings have shown that p53 expression can influence DNA adduct formation of the environmental carcinogen benzo[a]pyrene (BaP) in human cells, indicating a role for p53 in the cytochrome P450 (CYP) 1A1-mediated biotransformation of BaP in vitro. We investigated the potential role of p53 in xenobiotic metabolism in vivo by treating Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice with BaP. BaP-DNA adduct levels, as measured by (32)P-postlabelling analysis, were significantly higher in liver and kidney of Trp53(-/-) mice than of Trp53(+/+) mice. Complementarily, significantly higher amounts of BaP metabolites were also formed ex vivo in hepatic microsomes from BaP-pretreated Trp53(-/-) mice. Bypass of the need for metabolic activation by treating mice with BaP-7,8-dihydrodiol-9,10-epoxide resulted in similar adduct levels in liver and kidney in all mouse lines, confirming that the influence of p53 is on the biotransformation of the parent compound. Higher BaP-DNA adduct levels in the livers of Trp53(-/-) mice correlated with higher CYP1A protein levels and increased CYP1A enzyme activity in these animals. Our study demonstrates a role for p53 in the metabolism of BaP in vivo, confirming previous in vitro results on a novel role for p53 in CYP1A1-mediated BaP metabolism. However, our results also suggest that the mechanisms involved in the altered expression and activity of the CYP1A1 enzyme by p53 in vitro and in vivo are different.
650    _2
$a metabolická aktivace $7 D065767
650    _2
$a zvířata $7 D000818
650    _2
$a benzopyren $x metabolismus $x farmakokinetika $7 D001564
650    _2
$a karcinogeny životního prostředí $x metabolismus $x farmakokinetika $7 D002274
650    _2
$a cytochrom P-450 CYP1A1 $x metabolismus $7 D019363
650    _2
$a adukty DNA $x metabolismus $7 D018736
650    _2
$a poškození DNA $x účinky léků $x genetika $7 D004249
650    _2
$a metabolická inaktivace $7 D008658
650    _2
$a ledviny $x účinky léků $x metabolismus $7 D007668
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a mutantní kmeny myší $7 D008817
650    _2
$a jaterní mikrozomy $x účinky léků $x metabolismus $7 D008862
650    _2
$a NAD(P)H dehydrogenasa (chinon) $x metabolismus $7 D016660
650    _2
$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Speksnijder, Ewoud N $u Center for Health Protection, National Institute for Public Health and the Environment (RIVM), 3721 MA, Bilthoven, The Netherlands. Department of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
700    1_
$a Melis, Joost P M $u Center for Health Protection, National Institute for Public Health and the Environment (RIVM), 3721 MA, Bilthoven, The Netherlands. Department of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
700    1_
$a Indra, Radek $u Department of Biochemistry, Faculty of Science, Charles University, 12840, Prague 2, Czech Republic.
700    1_
$a Moserova, Michaela $u Department of Biochemistry, Faculty of Science, Charles University, 12840, Prague 2, Czech Republic.
700    1_
$a Godschalk, Roger W $u Department of Toxicology, School for Nutrition, Toxicology and Metabolism (NUTRIM), Maastricht University Medical Centre, 6200 MD, Maastricht, The Netherlands.
700    1_
$a van Schooten, Frederik-J $u Department of Toxicology, School for Nutrition, Toxicology and Metabolism (NUTRIM), Maastricht University Medical Centre, 6200 MD, Maastricht, The Netherlands.
700    1_
$a Seidel, Albrecht $u Biochemical Institute for Environmental Carcinogens, Prof. Dr. Gernot Grimmer-Foundation, 22927, Grosshansdorf, Germany.
700    1_
$a Kopka, Klaus $u Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
700    1_
$a Schmeiser, Heinz H $u Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
700    1_
$a Stiborova, Marie $u Department of Biochemistry, Faculty of Science, Charles University, 12840, Prague 2, Czech Republic.
700    1_
$a Phillips, David H $u Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
700    1_
$a Luijten, Mirjam $u Center for Health Protection, National Institute for Public Health and the Environment (RIVM), 3721 MA, Bilthoven, The Netherlands. Department of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
700    1_
$a Arlt, Volker M. $u Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK. volker.arlt@kcl.ac.uk. $7 xx0074763 $4
773    0_
$w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 90, č. 4 (2016), s. 839-51
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25995008 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170112121429 $b ABA008
999    __
$a ok $b bmc $g 1180276 $s 961703
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 90 $c 4 $d 839-51 $e 20150521 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...